The
Cooper Companies (COO), a staple in the
contact lenses and
women's health market, has seen a varied performance in the past. There have been some instances of
stock sell-offs from various players, including Meridian Growth Fund, Citigroup, Charles Schwab Investment Management, and Massachusetts Financial Services. However, others have
increased their holdings such as BNP Paribas, Bank of Montreal, LMR Partners, and Thrivent Financial for Lutherans.
Various outlets have noted this uneven performance, with some recognizing Cooper as a strong investment and others pointing to a possible undervaluation. The company's stocks have seen a
7.5% CAGR over the last five years, but the figures have also indicated a fluctuation, sometimes dipping, other times rallying.
The company posted some impressive Q3 results, beating estimates. A large contributor to these gains are the company’s
surgical products and strong contact lenses demand. Furthermore, the company's acquisition of OBP Surgical has broadened its CooperSurgical portfolio. However, its attempt to buy Cook Medical's reproductive health business for $875 million could potentially lead to overheating due to the many acquisitions. Recent management changes and a stock split announcement have also stirred the waters.
The Cooper Companies COO News Analytics from Sat, 05 Dec 2015 08:00:00 GMT to Sat, 30 Nov 2024 09:49:29 GMT -
Rating 3
- Innovation 5
- Information 8
- Rumor 2
